What conditions does Chipscreen Biosciences, Ltd. run trials for?

In our tracked recruiting trials, Chipscreen Biosciences, Ltd. sponsors trials for Colorectal Cancer, Glioblastoma, Adult, Lung cancer.

Clinical trials sponsored by Chipscreen Biosciences, Ltd.

Recruiting trials

Conditions studied

Phase 1 2Phase 2 1Phase 3 1

Condition	Trials
Colorectal Cancer	1
Glioblastoma, Adult	1
Lung cancer	1
Neoplasms	1
Plaque Psoriasis	1
Psoriasis	1
Small Cell Lung Carcinoma (SCLC)	1

A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
NCT06497985 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
NCT07129382 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 11 locations
Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
NCT06902350 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Chipscreen Biosciences, Ltd. is the lead sponsor of 3 recruiting trials.

No. For the full record, search ClinicalTrials.gov.